Cinven Set to Back Theramex Acquisition With €1.5 Billion Debt

Cinven is arranging about €1.5 billion ($1.7 billion) in debt financing from banks to back its acquisition of specialty pharmaceutical company Theramex. The financing will support the buyout, which is expected to close pending regulatory approvals. Cinven's move reflects continued private equity appetite for healthcare assets, with debt markets remaining accommodative for leveraged deals.